Puredutide (an analogue of Tirzepatide)

Dhs. 1,235.00 AED

In stock

Puredutide is a dual GLP-1 and GIP receptor agonist. This class of molecules is studied in the context of carbohydrate and lipid metabolism regulation.

Puredutide is described as a dual incretin receptor agonist that activates both GLP-1 and GIP receptors. The stated purity of the material is at least 99%.

The molecule acts on two receptor systems:

GLP-1 receptors — associated with appetite and satiety signaling in the hypothalamus and insulin secretion.
GIP receptors — involved in the insulin response and the function of adipose tissue.

The combination of these two pathways in a single molecule distinguishes dual agonists from conventional GLP-1 receptor agonists, which primarily target one receptor system.

Dual GLP-1/GIP receptor agonists are studied in the context of metabolism, insulin response, and body weight regulation. Puredutide is intended exclusively for research and professional use and is not a medicinal product.

Puredutide is supplied in a syringe pen format. The stated material purity is at least 99%. Certificates of conformity are available, and batch purity is subject to verification.

We deliver throughout Dubai. Once you place your order, our manager will contact you to confirm product availability. Payment is due after your order has been confirmed.